fda compounding glp-1 enforcement news november 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Congress Introduces SAFE Drugs Act

The recent rise in GLP-1 receptor agonist prescriptions has resulted in a medication shortage, according to Yee Hui Yeo, MD, MSc, from Cedars-Sinai Medical Center, and colleagues

By implementing strategies to maintain optimal glutathione levels through diet, lifestyle, and potentially supplementation, men can better support their body's natural recovery processes and potentially achieve improved training outcomes

The medication was well tolerated and all patients reported prompt resolution of their symptoms over a mean duration of 19.8 months of follow-up

Rare but serious (seek medical attention): Significant swelling of face, hands, feet

Rather than broadly applying this therapy if it is approved, we suggest careful patient selection and monitoring by clinicians pending further studies